AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
Form_NN
20-F_NN
Information_NOMZ
2004_CD
99_CD
28_CD
Post-retirement_NOMZ
benefits_NN
Pensions_NN
Background_NN
The_NN
Group_NN
continues_VPRT
to_TO
account_VB
for_PIN
pension_NN
costs_NN
in_PIN
its_PIT
primary_JJ
Financial_NN
Statements_NOMZ
in_PIN
accordance_NN
with_PIN
the_DT
UK_NN
Statement_NOMZ
of_PIN
Standard_NN
Accounting_GER
Practice_NN
No._NN
._.
In_CONJ
addition_NULL
,_,
disclosures_NN
have_VPRT [PEAS]
been_VBN [PASS]
presented_VBN
below_PLACE
in_PIN
accordance_NN
with_PIN
Financial_NN
Reporting_GER
Standard_NN
No._NN
._.
The_DT
Company_NN
and_CC
most_EMPH
of_PIN
its_PIT
subsidiaries_NN
offer_VPRT
retirement_NOMZ
plans_NN
which_WDT [WHSUB]
cover_VPRT
the_DT
majority_NOMZ
of_PIN
employees_NN
in_PIN
the_DT
Group_NN
._.
Many_QUAN
of_PIN
these_DEMO
plans_NN
are_VPRT [PASS]
defined_VBN
contribution_NOMZ
where_RB
the_DT
company_NN
contribution_NOMZ
and_CC
resulting_VBG
profit_NN
and_PHC
loss_NN
account_NN
charge_NN
is_VPRT [PASS]
fixed_VBN
at_PIN
a_DT
set_VBN
level_NN
or_CC
is_VPRT [BEMA]
a_DT
set_NN
percentage_NN
of_PIN
employees_NN
pay_VPRT
._.
However_CONJ
,_,
several_QUAN
plans_NN
,_,
mainly_RB
in_PIN
the_DT
UK_NN
,_,
the_DT
US_FPP1
and_PHC
Sweden_NN
,_,
are_VPRT [PASS]
defined_VBN
benefit_NN
,_,
where_RB
benefits_NN
are_VPRT [PASS]
based_VBN
on_PIN
employees_NN
length_NN
of_PIN
service_NN
and_CC
average_JJ
final_JJ
salary_NN
typically_RB
averaged_VBD
over_IN
1_CD
,_,
3_CD
or_CC
5_CD
years_NN
._.
All_QUAN
of_PIN
the_DT
major_JJ
plans_NN
are_VPRT [PASS]
funded_VBN
through_PIN
legally_RB
separate_JJ
trustee_NN
administered_VBN
funds_NN
._.
The_DT
major_JJ
defined_VBN
benefit_NN
plans_NN
,_,
apart_RB
from_PIN
the_DT
collectively_RB
bargained_VBN
Swedish_JJ
plan_NN
,_,
have_VPRT [PEAS]
been_VBN [PASS]
closed_VBN
to_PIN
new_JJ
entrants_NN
since_OSUB
2000_CD
._.
The_DT
cash_NN
funding_GER
of_PIN
the_DT
plans_NN
,_,
which_WDT [SERE]
may_POMD
from_PIN
time_NN
to_PIN
time_NN
involve_VB
special_JJ
payments_NOMZ
,_,
is_VPRT [PASS]
designed_VBN
,_,
in_PIN
consultation_NOMZ
with_PIN
independent_JJ
qualified_JJ
actuaries_NN
,_,
to_TO
ensure_VB [SUAV] [PRIV]
that_THVC
the_DT
assets_NN
together_RB
with_PIN
future_JJ
contributions_NOMZ
should_NEMD
be_VB [BEMA]
sufficient_PRED
to_TO
meet_VB
future_JJ
liabilities_NOMZ
._.
The_DT
Group_NN
is_VPRT [SPAU]
currently_RB
performing_VBG
a_DT
global_JJ
review_NN
of_PIN
its_PIT
asset_NN
strategies_NN
with_PIN
a_DT
view_NN
to_TO
producing_VBG
a_DT
more_EMPH
globally_RB
consistent_JJ
investment_NOMZ
strategy_NN
for_PIN
each_QUAN
of_PIN
the_DT
Groups_NN
major_JJ
funds_NN
._.
This_DEMP
has_VPRT [PEAS]
been_VBN [PASS]
completed_VBN
in_PIN
the_DT
UK_NN
and_CC
is_VPRT
nearing_VBG
completion_NOMZ
in_PIN
the_DT
US_FPP1
,_,
Sweden_NN
and_PHC
Japan_NN
._.
SSAP_NN
24_CD
The_DT
cost_NN
of_PIN
defined_VBN
benefit_NN
plan_NN
pensions_NN
in_PIN
a_DT
year_NN
can_POMD [SPAU]
notionally_RB
be_VB [PASS]
divided_VBN
into_PIN
the_DT
regular_JJ
cost_NN
and_PHC
variations_NOMZ
from_PIN
the_DT
regular_JJ
cost_NN
._.
Under_IN
SSAP_NN
24_CD
the_DT
regular_JJ
cost_NN
is_VPRT [PASS]
based_VBN
on_PIN
actuarial_JJ
assumptions_NOMZ
and_CC
charged_VBN
to_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
in_PIN
the_DT
year_NN
it_PIT
is_VPRT [PASS]
incurred_VBN
whilst_OSUB
any_QUAN
variations_NOMZ
,_,
which_WDT [SERE]
arise_VPRT
where_RB
the_DT
experience_NN
of_PIN
the_DT
scheme_NN
varies_VPRT
from_PIN
the_DT
assumptions_NOMZ
made_VBN [WZPAST]
by_PIN
the_DT
actuary_NN
,_,
are_VPRT [PASS]
charged_VBN
or_CC
credited_VBN
over_IN
the_DT
estimated_VBN [PRIV]
remaining_VBG
service_NN
lives_NN
of_PIN
the_DT
employees_NN
._.
Costs_NN
of_PIN
defined_VBN
contribution_NOMZ
plan_NN
pensions_NN
are_VPRT [PASS]
charged_VBN
to_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
immediately_TIME
._.
On_PIN
these_DEMO
bases_NN
,_,
the_DT
total_JJ
pension_NN
cost_NN
for_PIN
the_DT
Group_NN
under_IN
SSAP_NN
24_CD
for_PIN
2004_CD
was_VBD
$_$
266m_CD
2003_CD
$_$
272m_CD
,_,
2002_CD
$_$
220m_CD
._.
In_PIN
the_DT
Group_NN
balance_NN
sheet_NN
at_PIN
31_CD
December_NN
2004_CD
,_,
accrued_VBN
pension_NN
costs_NN
included_VBD
in_PIN
other_JJ
creditors_NN
amounted_VBD
to_TO
$_$
111m_CD
2003_CD
$_$
143m_CD
:_:
prepaid_JJ
pension_NN
costs_NN
of_PIN
$_$
660m_CD
2003_CD
$_$
628m_CD
are_VPRT [PASS]
included_VBN
in_PIN
debtors_NN
._.
Provisions_NN
for_PIN
unfunded_JJ
pension_NN
obligations_NOMZ
,_,
included_VBD
in_PIN
provisions_NN
,_,
amounted_VBD
to_TO
$_$
304m_CD
2003_CD
$_$
283m_CD
._.
UK_NN
With_PIN
regard_NN
to_PIN
the_DT
Groups_NN
main_JJ
UK_NN
defined_VBD
benefit_NN
fund_NN
,_,
the_DT
latest_JJ
full_JJ
actuarial_JJ
valuation_NOMZ
was_VBD [PASS]
carried_VBN
out_PIN
at_PIN
31_CD
March_NN
2003_CD
and_CC
the_DT
pension_NN
cost_NN
assessed_VBN
using_VBG
the_DT
projected_VBN
unit_NN
credit_NN
method_NN
._.
The_DT
key_JJ
accounting_GER
assumptions_NOMZ
for_PIN
the_DT
purposes_NN
of_PIN
SSAP_NN
24_CD
were_VBD
that_DEMP
,_,
against_PIN
a_DT
background_NN
of_PIN
long_JJ
term_NN
UK_NN
price_NN
inflation_NOMZ
averaging_VBG [WZPRES]
2.4_CD
%_NN
pa_NN
,_,
investment_NOMZ
returns_NN
would_PRMD
average_VB
6.6_CD
%_NN
pa_NN
,_,
salary_NN
increases_NN
3.7_CD
%_NN
pa_NN
and_PHC
pension_NN
increases_NN
2.4_CD
%_NN
pa._NN
._.
The_DT
market_NN
value_NN
of_PIN
the_DT
funds_NN
assets_NN
at_PIN
the_DT
valuation_NOMZ
date_NN
was_VBD [BEMA]
2,043_CD
m_NN
$_$
3,640_CD
m_NN
equivalent_NN
,_,
representing_VBG [PRESP]
89.1_CD
%_NN
of_PIN
the_DT
liabilities_NOMZ
using_VBG [WZPRES]
these_DEMO
assumptions_NOMZ
._.
The_DT
cost_NN
for_PIN
accounting_GER
purposes_NN
equates_VPRT
to_PIN
21.1_CD
%_NN
of_PIN
pensionable_JJ
salaries_NN
._.
At_PIN
the_DT
same_JJ
time_NN
,_,
the_DT
valuation_NOMZ
was_VBD [PASS]
carried_VBN
out_PIN
for_PIN
ongoing_JJ
funding_GER
purposes_NN
,_,
with_PIN
assumptions_NOMZ
slightly_DWNT
more_EMPH
conservative_JJ
than_PIN
those_DEMP
used_VBN
for_PIN
SSAP_NN
24_CD
purposes_NN
._.
The_DT
market_NN
value_NN
of_PIN
the_DT
funds_NN
assets_NN
at_PIN
the_DT
valuation_NOMZ
date_NN
represents_VPRT
87.4_CD
%_NN
of_PIN
the_DT
liabilities_NOMZ
on_PIN
a_DT
funding_GER
basis_NN
._.
The_DT
Company_NN
had_VBD [PEAS]
indicated_VBN [PRIV]
to_PIN
the_DT
trustee_NN
of_PIN
the_DT
UK_NN
fund_NN
its_PIT
intention_NOMZ
to_TO
target_VB
a_DT
solvency_NN
ratio_NN
of_PIN
91_CD
%_NN
following_VBG [WZPRES]
the_DT
March_NN
2003_CD
actuarial_JJ
valuation_NOMZ
._.
A_DT
$_$
165m_CD
contribution_NOMZ
was_VBD [PASS]
made_VBN
in_PIN
November_NN
2003_CD
which_WDT
took_VBD
the_DT
solvency_NN
ratio_NN
to_PIN
95_CD
%_NN
._.
An_DT
interim_JJ
valuation_NOMZ
was_VBD [BYPA]
performed_VBN
by_PIN
the_DT
funds_NN
actuaries_NN
,_,
at_PIN
31_CD
March_NN
2004_CD
._.
The_DT
key_JJ
accounting_GER
assumptions_NOMZ
,_,
set_VBN [PASTP]
out_PIN
in_PIN
a_DT
manner_NN
consistent_JJ
with_PIN
the_DT
2003_CD
valuation_NOMZ
,_,
were_VBD [PASS]
revised_VBN
having_VBG
regard_NN
to_PIN
the_DT
investment_NOMZ
conditions_NOMZ
at_PIN
31_CD
March_NN
2004_CD
._.
The_DT
long_JJ
term_NN
UK_NN
price_NN
inflation_NOMZ
was_VBD [PASS]
set_VBN
at_PIN
2.75_CD
%_NN
pa_NN
,_,
salary_NN
increases_NN
at_PIN
4.0_CD
%_NN
pa_NN
,_,
pension_NN
increases_NN
at_PIN
2.75_CD
%_NN
pa_NN
and_PHC
investment_NOMZ
returns_NN
at_PIN
6.9_CD
%_NN
pa._NN
._.
The_DT
market_NN
value_NN
of_PIN
the_DT
funds_NN
assets_NN
at_PIN
the_DT
valuation_NOMZ
date_NN
was_VBD [BEMA]
2,453_CD
m_NN
$_$
4,502_CD
m_NN [BEMA]
equivalent_PRED
representing_VBG
a_DT
solvency_NN
ratio_NN
of_PIN
96.1_CD
%_NN
on_PIN
the_DT
funds_NN
liabilities_NOMZ
._.
The_DT
longer_JJ
term_NN
aim_NN
is_VPRT
to_TO
restore_VB
solvency_NN
over_IN
a_DT
period_NN
of_PIN
around_PLACE
15_CD
years_NN
._.
Any_QUAN
cash_NN
contributions_NOMZ
made_VBD
to_PIN
the_DT
fund_NN
are_VPRT [PASS]
treated_VBN
as_IN
prepayments_NOMZ
and_CC
taken_VBN
into_PIN
account_NN
in_PIN
the_DT
actuarially_RB
assessed_VBN
contributions_NOMZ
to_PIN
the_DT
fund_NN
charged_VBN [WZPAST]
to_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
._.
US_FPP1
The_NN
US_FPP1
defined_VBD
benefits_NN
program_NN
was_VBD [SPAU] [PASS]
actuarially_RB
revalued_VBN
at_PIN
31_CD
December_NN
2004_CD
when_RB
plan_NN
obligations_NOMZ
were_VBD [PASS]
estimated_VBN [PRIV]
to_TO
amount_VB
to_TO
$_$
1,199_CD
m_NN
and_PHC
plan_NN
assets_NN
were_VBD
$_$
1,064_CD
m._FW
The_DT
US_FPP1
typically_RB
makes_VPRT
contributions_NOMZ
to_TO
mitigate_VB
for_PIN
plan_NN
benefit_VPRT
deficits_NN
on_PIN
a_DT
regular_JJ
basis_NN
._.
Sweden_NN
The_NN
Swedish_NN
defined_VBD
benefits_NN
program_NN
was_VBD [SPAU] [PASS]
actuarially_RB
revalued_VBN
at_PIN
31_CD
December_NN
2004_CD
when_RB
plan_NN
obligations_NOMZ
were_VBD [PASS]
estimated_VBN [PRIV]
to_TO
amount_VB
to_TO
$_$
651m_CD
and_CC
plan_NN
assets_NN
were_VBD
$_$
539m_CD
._.
AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
100_CD
Form_NN
20-F_JJ
Information_NOMZ
2004_CD
Notes_NN
to_PIN
the_DT
Financial_NN
Statements_NOMZ
continued_VBD
28_CD
Post-retirement_NOMZ
benefits_NN
continued_VBD
Post-retirement_JJ
benefits_NN
other_JJ
than_PIN
pensions_NN
In_PIN
the_DT
US_FPP1
,_,
and_ANDC
to_PIN
a_DT
lesser_JJ
extent_NN
in_PIN
some_QUAN
other_JJ
countries_NN
,_,
AstraZenecas_NN
employment_NOMZ
practices_NN
include_VPRT
the_DT
provision_NN
of_PIN
healthcare_NN
and_PHC
life_NN
insurance_NN
benefits_NN
for_PIN
retired_VBN
employees_NN
._.
Some_QUAN
3,758_CD
retired_VBN
employees_NN
and_CC
covered_VBD
dependants_NN
currently_RB
benefit_VPRT
from_PIN
these_DEMO
provisions_NN
and_CC
some_QUAN
14,554_CD
current_JJ
employees_NN
will_PRMD
be_VB [BEMA]
eligible_PRED
on_PIN
retirement_NOMZ
._.
AstraZeneca_NN
accrues_VPRT
for_PIN
the_DT
present_JJ
value_NN
of_PIN
such_JJ
retiree_NN
obligations_NOMZ
over_IN
the_DT
working_VBG
life_NN
of_PIN
the_DT
employee_NN
._.
The_DT
cost_NN
of_PIN
post-retirement_JJ
benefits_NN
other_JJ
than_PIN
pensions_NN
for_PIN
the_DT
Group_NN
in_PIN
2004_CD
was_VBD
$_$
11m_CD
2003_CD
$_$
10m_CD
,_,
2002_CD
$_$
22m_CD
._.
Provisions_NN
and_PHC
creditors_NN
set_VBN [WZPAST]
aside_RB
for_PIN
the_DT
benefit_NN
obligations_NOMZ
at_PIN
31_CD
December_NN
2004_CD
amounted_VBD
to_TO
$_$
22m_CD
2003_CD
$_$
28m_CD
,_,
2002_CD
$_$
32m_CD
._.
Other_JJ
than_PIN
these_DEMO
provisions_NN
and_PHC
creditors_NN
there_EX
were_VBD
plan_NN
assets_NN
amounting_VBG [WZPRES]
to_TO
$_$
217m_CD
in_PIN
the_DT
US_FPP1
at_PIN
31_CD
December_NN
2004_CD
._.
These_DEMO
benefit_NN
plans_NN
have_VPRT [PEAS]
been_VBN [PASS]
included_VBN
in_PIN
the_DT
disclosure_NN
of_PIN
post-retirement_JJ
benefits_NN
under_IN
FRS_NN
17_CD
._.
FRS_NN
17_CD
Full_NN
implementation_NOMZ
of_PIN
FRS_NN
17_CD
had_VBD [SPAU] [PEAS]
originally_TIME
been_VBN [PASS]
intended_VBN [SUAV]
for_PIN
accounting_GER
periods_NN
ending_VBG [WZPRES]
on_PIN
or_CC
after_IN
22_CD
June_NN
2003_CD
but_CC
has_VPRT [PEAS]
been_VBN [BYPA]
deferred_VBN
by_PIN
the_DT
Accounting_GER
Standards_NN
Board_NN
until_IN
accounting_GER
periods_NN
commencing_VBG [WZPRES]
on_PIN
or_CC
after_IN
1_CD
January_NN
2005_CD
._.
However_CONJ
,_,
the_DT
requirements_NOMZ
for_PIN
disclosure_NN
under_IN
FRS_NN
17_CD
between_PIN
its_PIT
issue_NN
and_CC
full_JJ
implementation_NOMZ
dates_NN
remain_VPRT
and_CC
this_DEMO
information_NOMZ
is_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
._.
When_RB
fully_AMP
adopted_VBN
,_,
the_DT
objective_NN
of_PIN
FRS_NN
17_CD
is_VPRT
to_TO
reflect_VB [PRIV]
the_DT
fair_JJ
value_NN
of_PIN
post-retirement_JJ
plan_NN
assets_NN
and_PHC
liabilities_NOMZ
and_CC
associated_VBN
charges_NN
in_PIN
the_DT
Financial_NN
Statements_NOMZ
._.
FRS_NN
17_CD
specifies_VPRT
how_RB
key_JJ
assumptions_NOMZ
should_NEMD
be_VB [PASS]
formulated_VBN
and_PHC
applied_VBN
:_:
these_DEMO
assumptions_NOMZ
are_VPRT [BEMA]
often_RB
different_PRED
to_PIN
the_DT
funding_GER
bases_NN
established_VBN [PRIV] [WZPAST]
by_PIN
the_DT
pension_NN
funds_NN
trustees_NN
or_CC
actuaries_NN
._.
The_DT
accounting_GER
requirements_NOMZ
of_PIN
FRS_NN
17_CD
are_VPRT
broadly_RB
as_IN
follows_VPRT
:_:
Post-retirement_NOMZ
scheme_NN
assets_NN
are_VPRT [PASS]
valued_VBN
at_PIN
market_NN
values_NN
at_PIN
the_DT
balance_NN
sheet_NN
date_NN
:_:
Post-retirement_NOMZ
scheme_NN
liabilities_NOMZ
are_VPRT [PASS]
measured_VBN
using_VBG
a_DT
projected_VBN
unit_NN
method_NN
and_CC
discounted_VBN
at_PIN
the_DT
current_JJ
rate_NN
of_PIN
return_NN
on_PIN
high_JJ
quality_NOMZ
corporate_JJ
bonds_NN
of_PIN
equivalent_JJ
term_NN
and_PHC
currency_NN
to_PIN
the_DT
liability_NOMZ
:_:
and_ANDC
The_DT
movement_NOMZ
in_PIN
the_DT
scheme_NN
surplus_NN
deficit_NN
excluding_VBG [WZPRES]
contributions_NOMZ
will_PRMD
be_VB [PASS]
split_VBN
between_PIN
operating_GER
charges_NN
and_PHC
financing_GER
items_NN
in_PIN
the_DT
profit_NN
and_PHC
loss_NN
account_NN
and_CC
,_,
in_PIN
the_DT
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
,_,
actuarial_JJ
gains_NN
and_PHC
losses_NN
._.
The_DT
FRS_NN
17_CD
financial_JJ
information_NOMZ
presented_VBN [WZPAST]
in_PIN
AstraZenecas_NN
2003_CD
Annual_JJ
Report_NN
was_VBD [PASS]
based_VBN
on_PIN
the_DT
position_NOMZ
and_PHC
performance_NN
of_PIN
the_DT
Groups_NN
main_JJ
defined_VBN
benefit_NN
schemes_NN
._.
Typically_RB
this_DEMP
included_VBN
information_NOMZ
for_PIN
schemes_NN
in_PIN
the_DT
UK_NN
,_,
the_DT
US_FPP1
,_,
Sweden_NN
,_,
Germany_NN
and_PHC
Japan_NN
._.
In_PIN
order_NN
to_TO
provide_VB
a_DT
more_EMPH
complete_JJ
presentation_NOMZ
,_,
AstraZeneca_NN
has_VPRT [PEAS]
collected_VBN
information_NOMZ
on_PIN
all_QUAN
of_PIN
the_DT
Groups_NN
global_JJ
defined_VBN
benefit_NN
schemes_NN
._.
The_DT
2003_CD
information_NOMZ
presented_VBN
below_PLACE
has_VPRT [PEAS]
been_VBN [PASS]
recalculated_VBN
on_PIN
that_DEMP
basis_NN
._.
Financial_NN
assumptions_NOMZ
Qualified_VBN
independent_JJ
actuaries_NN
have_VPRT [PEAS]
updated_VBN
the_DT
actuarial_JJ
valuations_NOMZ
of_PIN
the_DT
major_JJ
defined_VBN
benefit_NN
schemes_NN
operated_VBN [WZPAST]
by_PIN
the_DT
Group_NN
to_PIN
31_CD
December_NN
2004_CD
._.
The_DT
assumptions_NOMZ
used_VBN [WZPAST]
by_PIN
the_DT
actuaries_NN
are_VPRT [PASS]
chosen_VBN
from_PIN
a_DT
range_NN
of_PIN
possible_JJ
actuarial_JJ
assumptions_NOMZ
which_WDT [WHOBJ]
,_,
due_JJ
to_PIN
the_DT
long_JJ
term_NN
nature_NN
of_PIN
the_DT
scheme_NN
,_,
may_POMD
not_XX0
necessarily_RB
be_VB [PASS]
borne_VBN
out_PIN
in_PIN
practice_NN
._.
These_DEMO
assumptions_NOMZ
were_VBD
as_IN
follows_VPRT
:_:
2004_CD
2003_CD
Rest_VB
of_PIN
Rest_VB
of_PIN
UK_NN
Group_NN
UK_NN
Group_NN
Inflation_NOMZ
assumption_NOMZ
2.7_CD
%_NN
2.4_CD
%_NN
2.6_CD
%_NN
2.3_CD
%_NN
Rate_NN
of_PIN
increase_NN
in_PIN
salaries_NN
3.9_CD
%_NN
3.9_CD
%_NN
3.9_CD
%_NN
4.3_CD
%_NN
Rate_NN
of_PIN
increase_NN
in_PIN
pensions_NN
in_PIN
payment_NOMZ
2.7_CD
%_NN
0.7_CD
%_NN
2.6_CD
%_NN
0.6_CD
%_NN
Discount_NN
rate_NN
5.3_CD
%_NN
5.1_CD
%_NN
5.4_CD
%_NN
5.3_CD
%_NN
Long_JJ
term_NN
rate_NN
of_PIN
return_NN
expected_VBN [PRIV] [WZPAST]
at_PIN
31_CD
December_NN
Equities_NOMZ
8.3_CD
%_NN
8.6_CD
%_NN
8.3_CD
%_NN
8.7_CD
%_NN
Bonds_NN
5.1_CD
%_NN
5.3_CD
%_NN
5.1_CD
%_NN
5.8_CD
%_NN
Others_NN
5.6_CD
%_NN
4.7_CD
%_NN
4.2_CD
%_NN
3.9_CD
%_NN
AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
Form_NN
20-F_NN
Information_NOMZ
2004_CD
101_CD
28_CD
Post-retirement_NOMZ
benefits_NN
continued_VBD
Post-retirement_JJ
scheme_NN
deficit_NN
The_DT
post-retirement_JJ
scheme_NN
deficit_NN
set_VBN [WZPAST]
out_PIN
below_PLACE
under_IN
FRS_NN
17_CD
is_VPRT
as_IN
if_COND
this_DEMO
standard_NN
were_VBD [SPAU] [PASS]
fully_AMP
applied_VBN
._.
However_CONJ
,_,
under_IN
the_DT
current_JJ
accounting_GER
methodology_NN
SSAP_NN
24_CD
there_EX
are_VPRT
prepayments_NOMZ
and_PHC
provisions_NN
including_VBG [WZPRES]
deferred_JJ
tax_NN
within_PIN
the_DT
balance_NN
sheet_NN
at_PIN
31_CD
December_NN
2004_CD
that_DEMP
must_NEMD
be_VB [PASS]
taken_VBN
into_PIN
account_NN
in_PIN
calculating_VBG [PRIV]
the_DT
effect_NN
on_PIN
net_JJ
assets_NN
of_PIN
this_DEMO
deficit_NN
in_PIN
the_DT
event_NN
of_PIN
a_DT
restatement_NOMZ
under_IN
FRS_NN
17_CD
._.
The_DT
assets_NN
and_PHC
liabilities_NOMZ
of_PIN
the_DT
major_JJ
defined_VBN
benefit_NN
schemes_NN
operated_VBN [WZPAST]
by_PIN
the_DT
Group_NN
at_PIN
31_CD
December_NN
2004_CD
as_IN
calculated_VBN [PRIV]
in_PIN
accordance_NN
with_PIN
FRS_NN
17_CD
are_VPRT [PASS]
shown_VBN [PRIV]
below_PLACE
._.
The_DT
fair_JJ
values_NN
of_PIN
the_DT
schemes_NN
assets_NN
are_VPRT [PASS]
not_XX0
intended_VBN [SUAV]
to_TO
be_VB [PASS]
realized_VBN [PRIV]
in_PIN
the_DT
short_JJ
term_NN
and_CC
may_POMD
be_VB [BEMA]
subject_PRED
to_PIN
significant_JJ
change_NN
before_IN
they_TPP3
are_VPRT [PASS]
realized_VBN [PRIV]
._.
The_DT
present_JJ
value_NN
of_PIN
the_DT
schemes_NN
liabilities_NOMZ
is_VPRT [PASS]
derived_VBN
from_PIN
cash_NN
flow_NN
projections_NOMZ
over_IN
long_JJ
periods_NN
and_CC
is_VPRT
thus_CONJ
inherently_RB
uncertain_JJ
._.
If_COND
FRS_NN
17_CD
had_VBD [PEAS]
been_VBN [PASS]
adopted_VBN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2004_CD
,_,
the_DT
Groups_NN
reported_VBD [PUBV] [THATD]
net_JJ
assets_NN
see_VPRT [PRIV]
page_NN
74_CD
would_PRMD
be_VB [BYPA]
reduced_VBN
by_PIN
$_$
1,369_CD
m_NN [BEMA]
9.4_CD
%_NN
to_TO
$_$
13,150_CD
m._NN
Further_JJ
explanation_NOMZ
of_PIN
this_DEMO
adjustment_NOMZ
is_VPRT [PASS]
included_VBN
below_PLACE
:_:
Value_NN
at_PIN
31_CD
December_NN
2004_CD
Value_NN
at_PIN
31_CD
December_NN
2003_CD
Rest_VB
of_PIN
Rest_VB
of_PIN
UK_NN
Group_NN
Total_NN
UK_NN
Group_NN
Total_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Scheme_NN
assets_NN
Equities_NOMZ
2,083_CD
1,488_CD
3,571_CD
1,779_CD
1,182_CD
2,961_CD
Bonds_NN
2,007_CD
583_CD
2,590_CD
2,430_CD
530_CD
2,960_CD
Others_NN
927_CD
101_CD
1,028_CD
109_CD
87_CD
196_CD
Total_JJ
fair_JJ
value_NN
of_PIN
assets_NN
5,017_CD
2,172_CD
7,189_CD
4,318_CD
1,799_CD
6,117_CD
Present_JJ
value_NN
of_PIN
scheme_NN
liabilities_NOMZ
6,126_CD
2,766_CD
8,892_CD
5,232_CD
2,406_CD
7,638_CD
Deficit_NN
in_PIN
the_DT
scheme_NN
1,109_CD
594_CD
1,703_CD
914_CD
607_CD
1,521_CD
Related_VBN
deferred_VBN
tax_NN
asset_NN
333 187 520 274_CD
222_CD
496_CD
Net_JJ
post-retirement_JJ
deficit_NN
under_IN
FRS_NN
17 776 407_CD
1,183_CD
640_CD
385_CD
1,025_CD
Adjustments_NOMZ
for_PIN
assets_NN
and_PHC
provisions_NN
under_IN
SSAP_NN
24_CD
Prepayment_NOMZ
,_,
net_NN
of_PIN
related_JJ
deferred_JJ
tax_NN
204 265 469 203_CD
203_CD
406_CD
Accrual_NN
,_,
net_NN
of_PIN
deferred_JJ
tax_NN
52_CD
52_CD
19_CD
59_CD
78_CD
Provision_NN
,_,
net_NN
of_PIN
deferred_JJ
tax_NN
18 213 231 155_CD
155_CD
Adjusted_VBN
post-retirement_JJ
deficit_NN
,_,
net_NN
of_PIN
related_JJ
deferred_JJ
tax_NN
962_CD
407_CD
1,369_CD
824_CD
374_CD
1,198_CD
Net_JJ
assets_NN
as_IN
currently_RB
disclosed_VBN [PUBV]
see_VPRT [PRIV]
page_NN
74_CD
14,519_CD
13,257_CD
Net_JJ
assets_NN
as_IN
adjusted_VBN
if_COND
FRS_NN
17_CD
were_VBD [SPAU] [PASS]
fully_AMP
adopted_VBN
13,150_CD
12,059_CD
The_DT
present_JJ
value_NN
of_PIN
the_DT
UK_NN
schemes_NN
liabilities_NOMZ
has_VPRT [PEAS]
increased_VBN
to_TO
$_$
6,126_CD
m_NN [BEMA]
from_PIN
$_$
5,232_CD
m_NN [BEMA]
in_PIN
2003_CD
._.
This_DEMO
increase_NN
has_VPRT [PEAS]
been_VBN [PASS]
driven_VBN
in_PIN
part_NN
by_PIN
the_DT
changes_NN
in_PIN
financial_JJ
assumptions_NOMZ
detailed_VBN [WZPAST]
on_PIN
page_NN
100_CD
._.
There_EX
has_VPRT [SPAU] [PEAS]
also_RB
been_VBN [BEMA]
an_DT
exchange_NN
effect_NN
of_PIN
approximately_RB
$_$
271m_CD
on_PIN
these_DEMO
liabilities_NOMZ
during_PIN
the_DT
year_NN
._.
95_CD
%_NN
of_PIN
the_DT
Groups_NN
liabilities_NOMZ
at_PIN
31_CD
December_NN
2004_CD
are_VPRT [BEMA]
in_PIN
schemes_NN
within_PIN
the_DT
UK_NN
,_,
the_DT
US_FPP1
,_,
Sweden_NN
,_,
Germany_NN
and_PHC
Japan_NN
._.
AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
102_CD
Form_NN
20-F_JJ
Information_NOMZ
2004_CD
Notes_NN
to_PIN
the_DT
Financial_NN
Statements_NOMZ
continued_VBD
28_CD
Post-retirement_NOMZ
benefits_NN
continued_VBD
Profit_NN
and_PHC
loss_NN
account_NN
disclosures_NN
On_PIN
full_JJ
adoption_NOMZ
of_PIN
FRS_NN
17_CD
,_,
on_PIN
the_DT
basis_NN
of_PIN
the_DT
above_PLACE
assumptions_NOMZ
,_,
the_DT
amounts_NN
that_TSUB
would_PRMD
have_VB [PEAS]
been_VBN [PASS]
charged_VBN
to_PIN
the_DT
consolidated_JJ
profit_NN
and_PHC
loss_NN
account_NN
and_PHC
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
,_,
in_PIN
respect_NN
of_PIN
defined_VBN
benefit_NN
schemes_NN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2004_CD
are_VPRT [PASS]
set_VBN
out_PIN
below_PLACE
:_:
2004_CD
2003_CD
Rest_VB
of_PIN
Rest_VB
of_PIN
UK_NN
Group_NN
Total_NN
UK_NN
Group_NN
Total_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Operating_GER
profit_NN
Current_JJ
service_NN
cost_NN
124 116 240 110_CD
91_CD
201_CD
Past_JJ
service_NN
costs_NN
2_CD
2_CD
Total_JJ
operating_VBG
charge_NN
124 116 240 110_CD
93_CD
203_CD
Finance_NN
expense_NN
Expected_VBN [PRIV]
return_NN
on_PIN
post-retirement_JJ
scheme_NN
assets_NN
278 112 390 211_CD
66_CD
277_CD
Interest_NN
on_PIN
post-retirement_JJ
scheme_NN
liabilities_NOMZ
283 118 401 239_CD
91_CD
330_CD
Net_NN
return_NN
5_CD
6_CD
11_CD
28_CD
25_CD
53_CD
Charge_NN
before_IN
taxation_NOMZ
129 122 251 138_CD
118_CD
256_CD
Consolidated_NN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
Actual_JJ
return_NN
less_RB
expected_JJ
return_NN
on_PIN
the_DT
post-retirement_JJ
schemes_NN
assets_NN
138 54 192 210_CD
75_CD
285_CD
Experience_NN
losses_NN
arising_VBG [WZPRES]
on_PIN
the_DT
post-retirement_JJ
schemes_NN
liabilities_NOMZ
57_CD
9_CD
66_CD
6_CD
33_CD
39_CD
Changes_NN
in_PIN
assumptions_NOMZ
underlying_VBG [WZPRES]
the_DT
present_JJ
value_NN
of_PIN
the_DT
post-retirement_JJ
schemes_NN
liabilities_NOMZ
159 74 233 350_CD
116_CD
466_CD
Actuarial_JJ
loss_NN
recognized_VBN [PRIV]
78 29 107 146_CD
74_CD
220_CD
History_NN
of_PIN
experience_NN
gains_NN
and_PHC
losses_NN
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2004 2004 2003_CD
Rest_VB
of_PIN
Rest_VB
of_PIN
UK_NN
Group_NN
Total_NN
UK_NN
Group_NN
Total_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Difference_NN
between_PIN
the_DT
expected_VBN [PRIV]
and_CC
actual_JJ
return_NN
on_PIN
scheme_NN
assets_NN
:_:
Amount_NN
138 54 192 210_CD
75_CD
285_CD
Percentage_NN
of_PIN
scheme_NN
assets_NN
2.8_CD
%_NN
2.5_CD
%_NN
2.7_CD
%_NN
4.9_CD
%_NN
4.2_CD
%_NN
4.7_CD
%_NN
Experience_NN
gains_NN
and_PHC
losses_NN
on_PIN
scheme_NN
liabilities_NOMZ
:_:
Amount_NN
57_CD
9_CD
66_CD
6_CD
33_CD
39_CD
Percentage_NN
of_PIN
the_DT
present_JJ
value_NN
of_PIN
scheme_NN
liabilities_NOMZ
1.0_CD
%_NN
0.3_CD
%_NN
0.7_CD
%_NN
0.1_CD
%_NN
1.4_CD
%_NN
0.5_CD
%_NN
Total_JJ
amount_NN
recognized_VBN [PRIV] [WZPAST]
in_PIN
statement_NOMZ
of_PIN
total_JJ
recognized_VBN [PRIV]
gains_NN
and_PHC
losses_NN
:_:
Amount_NN
78 29 107 146_CD
74_CD
220_CD
Percentage_NN
of_PIN
the_DT
present_JJ
value_NN
of_PIN
scheme_NN
liabilities_NOMZ
1.3_CD
%_NN
1.0_CD
%_NN
1.2_CD
%_NN
2.8_CD
%_NN
3.1_CD
%_NN
2.9_CD
%_NN
AstraZeneca_NN
Annual_JJ
Report_NN
and_PHC
Financial_NN
Statements_NOMZ
Form_NN
20-F_NN
Information_NOMZ
2004_CD
103_CD
28_CD
Post-retirement_NOMZ
benefits_NN
continued_VBD
Movement_NOMZ
in_PIN
post-retirement_JJ
scheme_NN
deficit_NN
during_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2004 2004 2003_CD
Rest_VB
of_PIN
Rest_VB
of_PIN
UK_NN
Group_NN
Total_NN
UK_NN
Group_NN
Total_NN
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Deficits_NN
in_PIN
schemes_NN
at_PIN
beginning_GER
of_PIN
year_NN
914_CD
607_CD
1,521_CD
842_CD
585_CD
1,427_CD
Current_JJ
service_NN
cost_NN
124 116 240 110_CD
91_CD
201_CD
Contributions_NOMZ
97 193 290 299_CD
243_CD
542_CD
Past_JJ
service_NN
cost_NN
2_CD
2_CD
Settlement_NOMZ
and_CC
curtailment_JJ
Other_JJ
finance_NN
income_NN
5_CD
6_CD
11_CD
28_CD
25_CD
53_CD
Actuarial_JJ
loss_NN
78 29 107 146_CD
74_CD
220_CD
Exchange_NN
85_CD
29_CD
114_CD
87_CD
73_CD
160_CD
Deficits_NN
in_PIN
schemes_NN
at_PIN
end_NN
of_PIN
year_NN
1,109_CD
594_CD
1,703_CD
914_CD
607_CD
1,521_CD
Adjusted_VBN
post-retirement_JJ
deficit_NN
,_,
net_NN
of_PIN
deferred_JJ
tax_NN
1,369_CD
1,198_CD
The_DT
increase_NN
in_PIN
the_DT
deficit_NN
during_PIN
2004_CD
reflects_VPRT [PRIV]
changes_NN
in_PIN
assumptions_NOMZ
in_PIN
calculating_VBG [PRIV]
liabilities_NOMZ
principally_RB
in_PIN
the_DT
UK_NN
funds_NN
and_PHC
exchange_NN
movements_NOMZ
offset_VBN [WZPAST]
by_PIN
contributions_NOMZ
made_VBN [WZPAST]
to_PIN
the_DT
funds_NN
and_CC
better_JJ
actual_JJ
returns_NN
on_PIN
plan_NN
assets_NN
than_PIN
expected_VBN [PRIV]
._.
Reserves_NN
note_VPRT [PRIV]
for_PIN
the_DT
year_NN
ended_VBD
31_CD
December_NN
2004 2004 2003_CD
Total_JJ
Total_JJ
$_$
m_CD
$_$
m_CD
Profit_NN
and_PHC
loss_NN
reserve_NN
excluding_VBG [WZPRES]
post-retirement_JJ
liability_NOMZ
11,606_CD
10,449_CD
Post-retirement_NOMZ
reserve_NN
1,369_CD
1,198_CD
Profit_NN
and_PHC
loss_NN
reserve_NN
under_IN
FRS_NN
17_CD
10,237_CD
9,251_CD
